{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:25:12Z","timestamp":1719620712192},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"DOI":"10.7759\/cureus.63408","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:15:35Z","timestamp":1719605735000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence and Clinical Characteristics of Drug-Induced Lung Disease Among Chemotherapy Recipients"],"prefix":"10.7759","author":[{"given":"Ruhsel","family":"C\u00f6r\u00fct","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozden","family":"Altunda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00fcsun","family":"Ey\u00fcbo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte P","year":"2022","unstructured":"Conte P, Ascierto PA, Patelli G, et al.. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment. ESMO Open. 2022, 7:100404. 10.1016\/j.esmoop.2022.100404","journal-title":"ESMO Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.11.005","article-title":"Pulmonary toxicity of chemotherapy","volume":"33","author":"Meadors M","year":"2006","unstructured":"Meadors M, Floyd J, Perry MC. Pulmonary toxicity of chemotherapy. Semin Oncol. 2006, 33:98-105. 10.1053\/j.seminoncol.2005.11.005","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2015.06.019","article-title":"Chemotherapy agents with known pulmonary side effects and their anesthetic and critical care implications","volume":"31","author":"Dana Oprea A","year":"2017","unstructured":"Dana Oprea A. Chemotherapy agents with known pulmonary side effects and their anesthetic and critical care implications. J Cardiothorac Vasc Anesth. 2017, 31:2227-35. 10.1053\/j.jvca.2015.06.019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/life12010048","article-title":"Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile","volume":"12","author":"Basak D","year":"2021","unstructured":"Basak D, Arrighi S, Darwiche Y, Deb S. Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile. Life (Basel). 2021, 12:48. 10.3390\/life12010048","journal-title":"Life (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101498","article-title":"Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: three case series","volume":"34","author":"Nakamura Y","year":"2021","unstructured":"Nakamura Y, Takimoto T, Kobayashi T, et al.. Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: three case series. Respir Med Case Rep. 2021, 34:101498. 10.1016\/j.rmcr.2021.101498","journal-title":"Respir Med Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0033-8389(03)00109-x","article-title":"High-resolution CT of drug-induced lung disease","volume":"40","author":"Erasmus JJ","year":"2002","unstructured":"Erasmus JJ, McAdams HP, Rossi SE. High-resolution CT of drug-induced lung disease. Radiol Clin North Am. 2002, 40:61-72. 10.1016\/s0033-8389(03)00109-x","journal-title":"Radiol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314959","article-title":"Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches","volume":"23","author":"Savin IA","year":"2022","unstructured":"Savin IA, Zenkova MA, Sen'kova AV. Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. Int J Mol Sci. 2022, 23:14959. 10.3390\/ijms232314959","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2023.14.3.17","article-title":"The role of biomarkers in guiding clinical decision-making in oncology","volume":"14","author":"Moore DC","year":"2023","unstructured":"Moore DC, Guinigundo AS. The role of biomarkers in guiding clinical decision-making in oncology. J Adv Pract Oncol. 2023, 14:15-37. 10.6004\/jadpro.2023.14.3.17","journal-title":"J Adv Pract Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1071","article-title":"National differences in reporting 'pneumonia' and 'pneumonia interstitial': an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions","volume":"14","author":"Koo LC","year":"2005","unstructured":"Koo LC, Clark JA, Quesenberry CP, et al.. National differences in reporting 'pneumonia' and 'pneumonia interstitial': an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions. Pharmacoepidemiol Drug Saf. 2005, 14:775-87. 10.1002\/pds.1071","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/app132312564","article-title":"Molecular biomarkers for predicting cancer patient radiosensitivity and radiotoxicity in clinical practice","volume":"13","author":"Gkikoudi A","year":"2023","unstructured":"Gkikoudi A, Kalospyros SA, Triantopoulou S, et al.. Molecular biomarkers for predicting cancer patient radiosensitivity and radiotoxicity in clinical practice. Appl Sci. 2023, 13:12564. 10.3390\/app132312564","journal-title":"Appl Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091181","article-title":"Promising biomarkers of radiation-induced lung injury: a review","volume":"9","author":"Liu X","year":"2021","unstructured":"Liu X, Shao C, Fu J. Promising biomarkers of radiation-induced lung injury: a review. Biomedicines. 2021, 9:1181. 10.3390\/biomedicines9091181","journal-title":"Biomedicines"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch S","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift AJ, et al.. Drug-induced interstitial lung disease: a systematic review. J Clin Med. 2018, 7:356. 10.3390\/jcm7100356","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0248","article-title":"High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases","volume":"18","author":"Tamura M","year":"2013","unstructured":"Tamura M, Saraya T, Fujiwara M, et al.. High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases. Oncologist. 2013, 18:454-9. 10.1634\/theoncologist.2012-0248","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-023-00227-x","article-title":"Systemic corticosteroids for treating respiratory diseases: less is better, but\u2026 when and how is it possible in real life?","volume":"9","author":"Melani AS","year":"2023","unstructured":"Melani AS, Croce S, Cassai L, et al.. Systemic corticosteroids for treating respiratory diseases: less is better, but\u2026 when and how is it possible in real life?. Pulm Ther. 2023, 9:329-44. 10.1007\/s41030-023-00227-x","journal-title":"Pulm Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000110204","article-title":"Genetic predisposition to respiratory diseases: infiltrative lung diseases","volume":"74","author":"Steele MP","year":"2007","unstructured":"Steele MP, Brown KK. Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration. 2007, 74:601-8. 10.1159\/000110204","journal-title":"Respiration"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2014.07.16","article-title":"Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer","volume":"6","author":"Kim S","year":"2014","unstructured":"Kim S, Oh IJ, Park SY, et al.. Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer. J Thorac Dis. 2014, 6:1209-17. 10.3978\/j.issn.2072-1439.2014.07.16","journal-title":"J Thorac Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijri.IJRI_178_19","article-title":"Chemotherapy-induced pulmonary complications in cancer: significance of clinicoradiological correlation","volume":"30","author":"Dhamija E","year":"2020","unstructured":"Dhamija E, Meena P, Ramalingam V, Sahoo R, Rastogi S, Thulkar S. Chemotherapy-induced pulmonary complications in cancer: significance of clinicoradiological correlation. Indian J Radiol Imaging. 2020, 30:20-6. 10.4103\/ijri.IJRI_178_19","journal-title":"Indian J Radiol Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266371-incidence-and-clinical-characteristics-of-drug-induced-lung-disease-among-chemotherapy-recipients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:15:39Z","timestamp":1719605739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266371-incidence-and-clinical-characteristics-of-drug-induced-lung-disease-among-chemotherapy-recipients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.63408","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}